Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival ...Middle East

Adding bemarituzumab to chemotherapy as first-line treatment for advanced gastric and gastroesophageal junction (GEJ) cancers improved survival over chemotherapy alone in the phase 2 FIGHT trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival )

Also on site :

• Japan starts deploying Osprey fleet at a new base to beef up southwestern defense
• South Africa seeks US trade deal after Trump’s 30% citrus tariff
• Josh O’Connor Goes Full Cowboy in ‘Rebuilding’ as Director Max Walker-Silverman Takes on Life After the Fires: ‘Loss Often Comes With Love’